Use of clot-busting drug for stroke has almost doubled

08/26/2013 | HealthDay News

An analysis of information from almost 1,700 U.S. hospitals found an increase in the use of clot-busting tissue plasminogen activator as a therapy for ischemic stroke, according to a study in the journal Circulation: Cardiovascular Quality and Outcomes. Among patients who were transported to hospitals swiftly and who did not have conditions that could increase the drug's risks, usage grew from 43% in 2003 to 77% in 2011. "We should be providing intravenous tPA to all eligible patients, which means that nearly a quarter of them are still missing that opportunity," researcher Dr. Lee Schwamm said.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN